2016 Hematological Malignancies

WHO Classification for HL (2001)

Classical HL (cHL)

Lymphocyte-rich classical HL (5%) Nodular Sclerosis (60-80%) Mixed Cellularity (25-30%) Lymphocyte Depletion (1%)

Nodular Lymphocyte predominant HL (5%)